Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Levilactobacillus brevis & Inflammatory Bowel Disease (IBD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

The novel Levilactobacillus brevis AL0035 counteracted weight loss, improved disease activity, and enhanced barrier integrity in TNBS-induced colitis in mice
Vesci et al. 2024 Nutrients 16(7): 937

Pasteurized forms of Levilactobacillus brevis IBRC-M10790 mitigated inflammatory responses and reduced pro-inflammatory cytokines in a gut co-culture model mimicking [Inflammatory Bowel Disease (IBD)](brain://UUceGF1S-UOZoI1l…

Lactobacillus brevis Alleviates DSS-Induced Colitis by Reprograming Intestinal Microbiota and Influencing Serum Metabolome in Murine Model
Ding et al. 2019a Front Physiol 10: 1152
Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier
Vesci et al. 2024 Nutrients 16(7): 937
Pasteurized form of a potential probiotic lactobacillus brevis IBRC-M10790 exerts anti-inflammatory effects on inflammatory bowel disease in vitro
Ebrahiminejad et al. 2024 BMC Complement Med Ther 24(1): 258

7/1/2026